Skip to main content
Year archive

Viking Therapeutics, Inc. — 2020 filings

All 32 regulatory filings released by Viking Therapeutics, Inc. (VKTX) in 2020, sourced directly from the official regulator.

32 Filings
2020 Period
2020 filings (32)
Filing Released Lang
10-Q
Interim / Quarterly Report 9M 2020
2020-10-28 English
8-K
Regulatory Filings
2020-10-28 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-16 English
FORM 4 SUBMISSION
Director's Dealing
2020-09-16 English
10-Q
Interim / Quarterly Report Q2 2020
2020-07-29 English
8-K
Regulatory Filings
2020-07-29 English
FORM 4 SUBMISSION
Director's Dealing
2020-06-30 English
8-K
Regulatory Filings
2020-05-21 English
DEFA14A
Regulatory Filings
2020-05-20 English
10-Q
Interim / Quarterly Report Q1 2020
2020-04-30 English
8-K
Regulatory Filings
2020-04-30 English
DEFA14A
Regulatory Filings
2020-04-06 English
DEF 14A
Proxy Solicitation & Information Statement
2020-04-06 English
FORM 4 SUBMISSION
Director's Dealing
2020-04-03 English
8-K
Regulatory Filings
2020-03-17 English
S-8
Registration Form
2020-02-26 English
10-K
Annual Report FY 2019
2020-02-26 English
Regulatory Filings 2020
Regulatory Filings
2020-02-19 English
SCHEDULE 13G HOLDINGS REPORT AMENDMENT
Major Shareholding Notification
2020-02-14 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-13 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-07 English
Major Shareholding Notification 2020
Major Shareholding Notification
2020-02-06 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-21 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-21 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English
FORM 4 SUBMISSION
Director's Dealing
2020-01-04 English